Evidence map›Paper›PMID 28837801›Full record

SynthesisChest2017

Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report.

Mark A Malesker, Priscilla Callahan-Lyon, Belinda Ireland, Richard S Irwin, CHEST Expert Cough Panel

Registry-linked trialOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Chest, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06142994 (Phase 4, Efficacy and Safety of Atusin CAP in the Treatment of Subjects With Acute Bronchitis in the Primary Healthcare Setting), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06142994 nacompletednot on this mapstarted 2024, after this paper: background citation

Phase 4, Efficacy and Safety of Atusin CAP in the Treatment of Subjects With Acute Bronchitis in the Primary Healthcare Setting: Prospective, Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-arm Clinical Study.

TypeinterventionalSponsorNeopharm Bulgaria Ltd.Ran2024 to 2024Enrolled310ConditionsAcute BronchitisArmsAtusin CAP, Placebo
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Diagnosis and Treatment of Adult Patients with Cough.Respiration; international review of thoracic diseases · 2025
    Guideline
  2. Honey for acute cough in children - a systematic review.European journal of pediatrics · 2023
    Pooled it
  3. Efficacy and safety of AtusinBMC pulmonary medicine · 2025
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Chronic Cough.Deutsches Arzteblatt international · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Commented on by
    2019
5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mark A MaleskerPharmacy Practice Department, Creighton University, Omaha, NE. Electronic address: markmalesker@creighton.edu.
Priscilla Callahan-LyonMercy Clinic, Adamstown, MD.
Belinda IrelandTheEvidenceDoc, Pacific, MO.
Richard S IrwinDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA.
CHEST Expert Cough Panel
Creighton University · USMercy Clinic Neurology · USUniversity of Massachusetts Chan Medical School · US

Funding

Functional mapping of peripheral and central circuits for airway protection and breathingOT2OD023854 · OD · UNIVERSITY OF FLORIDA · PI BOLSER, DONALD C · 2016 to 2020
$10.8M
Modeling the role of the NTS in the neurogenesis of airway defensive behaviorsR01HL131716 · NHLBI · UNIVERSITY OF FLORIDA · PI BOLSER, DONALD C, MORRIS, KENDALL FRANCIS · 2017 to 2020
$3.1M
Medical Research Council MR/K020293/1NHLBI NIH HHS R01 HL131716NIH HHS OT2 OD023854
6 · The paper itself

Abstract

backgroundAcute cough associated with the common cold (CACC) causes significant impairment in quality of life. Effective treatment approaches are needed for CACC. We conducted a systematic review on the management of CACC to update the recommendations and suggestions of the CHEST 2006 guideline on this topic.

methodsThis systematic review of randomized controlled trials (RCTs) asked the question: Is there evidence of clinically relevant treatment effects for pharmacologic or nonpharmacologic therapies in reducing the duration/severity of acute CACC? Studies of adults and pediatric patients with CACC were included and assessed for relevance and quality. Based on the systematic review, guideline suggestions were developed and voted on using the American College of Chest Physicians organization methodology.

resultsSix systematic reviews and four primary studies identified from updated literature searches for each of the reviews or from hand searching were included and reported data on 6,496 participants with CACC who received one or more of a variety of interventions. The studies used an assortment of descriptors and assessments to identify CACC.

conclusionsThe evidence supporting the management of CACC is overall of low quality. This document provides treatment suggestions based on the best currently available evidence and identifies gaps in our knowledge and areas for future research.

Indexed as

ConsensusPractice Guidelines as TopicAcute DiseaseAnti-Inflammatory Agents, Non-SteroidalCommon ColdComplementary TherapiesCoughHumansNonprescription DrugsRandomized Controlled Trials as TopicAnti-Inflammatory Agents, Non-SteroidalNonprescription Drugsacute coughcommon coldpharmacologic and nonpharmacologic treatment

Identifiers

PMID28837801
PMCPMC6026258
OpenAlexW2745887478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.